Psychological well-being in persons affected by Huntington's disease: a comparison of at-risk, prodromal, and symptomatic groups.

Journal of Health Psychology
Lauren Zeranski ChisholmRebecca E Ready

Abstract

In order to broaden knowledge of psychological functioning in Huntington's disease (HD), participants at-risk, prodromal, and symptomatic for HD reported on stress, negative affect, and depressive symptoms as well as life satisfaction, positive affect, and quality of life. Persons with symptomatic HD reported fewer psychological assets and greater stress, depressive symptoms, and negative affect than other groups. Positive affect in symptomatic persons did not significantly differ from other groups, and was higher in persons at-risk for HD than in controls. Greater attention to psychological assets in HD is warranted, particularly positive affect which may not decline early in the disease.

References

Jun 1, 1988·Journal of Personality and Social Psychology·D WatsonA Tellegen
Dec 1, 1983·Journal of Health and Social Behavior·S CohenR Mermelstein
Jan 1, 1993·American Journal of Medical Genetics·K A Quaid, M Morris
Jan 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·R A RoosG W Bruyn
Sep 1, 1996·Nursing Research·C T Beck
Jan 1, 1997·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·A TibbenH J Duivenvoorden
Mar 15, 1997·Lancet·G Evers-KieboomsK Demyttenaere
Dec 2, 1998·Patient Education and Counseling·G Evers-Kiebooms, M Decruyenaere
Sep 15, 2000·Acta Neurologica Scandinavica·T B Robins WahlinM Anvret
Apr 11, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·D I HelderR A Roos
Aug 21, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·J S PaulsenJ L Cummings
Sep 27, 2003·Journal of the American Geriatrics Society·Jason H T KarlawishDavid A Asch
Apr 1, 2005·The American Journal of Psychiatry·Jane S PaulsenLaura Stierman
Feb 1, 1985·Journal of Personality Assessment·E DienerS Griffin
Jan 3, 2006·The Journal of Neuropsychiatry and Clinical Neurosciences·Jane S PaulsenBeth Turner
Dec 21, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·Camille L JulienDavid Craufurd
Jan 24, 2007·Lancet·Francis O Walker
Mar 14, 2007·Brain Research Bulletin·Aad Tibben
May 8, 2007·Biological Psychiatry·Kevin DuffUNKNOWN Predict-HD Investigators of the Huntington Study Group
May 15, 2007·Journal of Clinical and Experimental Neuropsychology·Karin F HothAntoine Bechara
Dec 12, 2007·The Journal of Neuropsychiatry and Clinical Neurosciences·E van DuijnR C van der Mast
Jan 5, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Rebecca E ReadyJane S Paulsen
Nov 18, 2008·The Journal of Clinical Psychiatry·Leigh J BeglingerJulie C Stout
Dec 20, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Aileen K HoRoger A Barker
May 14, 2010·The Journal of Neuropsychiatry and Clinical Neurosciences·Kevin DuffUNKNOWN Predict-HD Investigators of the Huntington Study Group
Aug 9, 2011·Neurology Research International·Rebecca E ReadyJane S Paulsen

❮ Previous
Next ❯

Citations

Apr 30, 2015·Journal of Genetic Counseling·Jesús Rivera-NavarroNatividad Mariscal
Jan 23, 2019·Journal of Cellular Physiology·Tahereh FarkhondehMohsen Azimi-Nezhad
Sep 8, 2020·Journal of Huntington's Disease·Nicolò ZarottiJane Simpson
Aug 15, 2019·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Annie HawtonTimothy Harrower

❮ Previous
Next ❯

Software Mentioned

Survey Monkey

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.